| tadalafil | placebo |  |  |
---|
 | start | end | start | end | Pt
| Pgt
|
---|
Knee extension
| 64.2N (64.8%) | 56.7N (70.3%) | 97.7N (45.2%) | 80.3N (58.9%) |
0.01* |
0.05
|
Knee flexion
| 52.0N (66.1%) | 45.2N (70.7%) | 70.4N (52.9%) | 43.5N (71.8%) |
0.12
|
0.08
|
Foot dorsal flexion
| 79.6N (53.6%) | 84.3N (51.0%) | 102.5N (39.5%) | 81.4N (52.1%) |
0.40
|
0.28
|
Foot plantar flexion
| 93.0N (56.4%) | 100.2N (57.0%) | 134.6N (42.4%) | 76.1N (64.1%) |
0.05
|
0.34
|
- Results of the muscle force tests measured with the MicroFet 2 Dynamometer. Values indicate the differences in muscle strength between the CRPS affected and contralateral sides. All values are given in units of Newtons (percent difference between the two sides). The start and end times were when treatment started at t = 0 and ended at t = 12 weeks.
- Pt = P-value for differences over time; Pgt = P-value for interaction Group*Time